Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $4,122 | $30,544 | $11,958 | $9,274 |
| - Cash | $10,041 | $20,608 | $792 | $3,880 |
| + Debt | $2,196 | $1,197 | $7,952 | $1,655 |
| Enterprise Value | -$3,723 | $11,133 | $19,118 | $7,049 |
| Revenue | $666 | $1,148 | $867 | $7,305 |
| % Growth | -42% | 32.4% | -88.1% | – |
| Gross Profit | -$342 | -$699 | -$234 | $3,604 |
| % Margin | -51.4% | -60.9% | -27% | 49.3% |
| EBITDA | -$14,871 | -$15,706 | -$5,062 | -$2,213 |
| % Margin | -2,232.9% | -1,368.1% | -583.9% | -30.3% |
| Net Income | -$22,690 | -$46,095 | -$9,196 | -$6,708 |
| % Margin | -3,406.9% | -4,015.2% | -1,060.7% | -91.8% |
| EPS Diluted | -3.87 | -10.19 | -18.5 | -17.4 |
| % Growth | 62% | 44.9% | -6.3% | – |
| Operating Cash Flow | -$13,681 | -$16,993 | -$5,812 | -$8,660 |
| Capital Expenditures | -$617 | -$535 | -$60 | -$28 |
| Free Cash Flow | -$14,298 | -$17,528 | -$5,872 | -$8,688 |